← Open Payments lookup

MARY OGUNLOWO-OMOBHUDE: Open Payments

NPI 1508324971 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,801 in 83 payments from 14 companies in 2025. Trend: 2023 $393 · 2024 $2,445 · 2025 $1,801

Food & beverage: $1,700Education: $101
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.11$286
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$252
ABBVIE INC.11$235
Teva Pharmaceuticals USA, Inc.6$183
Neurocrine BioSciences, Inc.7$157
Alkermes, Inc.9$142
Lundbeck LLC5$108
Indivior Inc.3$97
Otsuka America Pharmaceutical, Inc.3$68
Supernus Pharmaceuticals, Inc.3$64

Products named: COBENFY, CAPLYTA, VRAYLAR, INGREZZA, ARISTADA, REXULTI, SUBLOCADE, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.